![John Mendlein](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
John Mendlein
Fondateur chez
Homes for Sudan
Fortune : 883 896 $ au 31/05/2026
Profil
John D.
Mendlein was the founder of Fate Therapeutics, Inc., founded in 2007, where the title held was Vice Chairman from 2011 to 2025.
Dr. Mendlein is also the founder of Empress Therapeutics, Inc.,Sail Biomedicines Inc,Homes for Sudan..
Dr. Mendlein is Executive Chairman at Vesalius Therapeutics, Inc. starting 2025.
Dr. Mendlein is Chairman at Chimeros Therapeutics.
Dr. Mendlein is Director at Tessera Therapeutics, Inc. Dr. Mendlein is Executive Partner at Flagship Pioneering, Inc. since 2019.
Former positions include Chairman & Chief Executive Officer at Adnexus from 2005 to 2008.
Chairman, CEO & General Counsel at Affinium Pharmaceuticals Ltd. from 2000 to 2005.
Chairman & Chief Executive Officer at Laronde, Inc. in 2022.
Director & Chief Knowledge Officer at Aurora Biosciences Corp.
from 1996 to 2001.
Director at ACLARA Biosciences, Inc. from 2003 to 2004.
Director at Monogram Biosciences, Inc. from 2004 to 2009.
Independent Director at aTyr Pharma, Inc. from 2017 to 2019.
Director at Chimeros, Inc. Director at Biotechnology Innovation Organization.
Independent Director at Omega Therapeutics, Inc. from 2021 to 2024.
Director at Axcella Health, Inc. Independent Director at Editas Medicine, Inc. Director at Repertoire Immune Medicines, Inc. Director at Senda Biosciences, Inc. Director at Ohana Biosciences, Inc. Attorney at Cooley LLP.
Scientist at GlaxoSmithKline Pharmaceuticals SA (Belgium).
President-Corporate & Product Strategy at Moderna, Inc. from 2018 to 2019.
Education includes a doctorate from the University of California, Los Angeles, an undergraduate degree from the University of Miami, and a graduate degree from the University of California, Hastings.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
FATE THERAPEUTICS, INC. 0,27 % | 29/05/2025 | 311 231 ( 0,27 % ) | 883 896 $ | 31/05/2026 |
Postes actifs de John Mendlein
| Sociétés | Poste | Début |
|---|---|---|
Chimeros Therapeutics
 Chimeros Therapeutics Medical SpecialtiesHealth Technology Develops cancer therapeutic treatment services | Président | 17/09/2009 |
Homes for Sudan | Fondateur | - |
Tessera Therapeutics, Inc.
 Tessera Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that writes therapeutic messages into the genome to treat diseases | Directeur/Membre du Conseil | - |
Flagship Pioneering, Inc.
 Flagship Pioneering, Inc. Investment ManagersFinance Flagship Pioneering invests in companies located across the globe. The firm targets companies operating in the fields of therapeutics, life science tools & diagnostics, bioenergy, and cleantech sectors. It provides financing for seed, early and later-stage capital requirements. The firm makes co-investments and also acts as a lead investor. | Private Equity Investor | 01/02/2019 |
Vesalius Therapeutics
 Vesalius Therapeutics BiotechnologyHealth Technology Operates as a biotechnology company that develops medicines for common human diseases | Président | 16/09/2025 |
Sail Biomedicines
 Sail Biomedicines Pharmaceuticals: MajorHealth Technology Engages in design and deployment of programmable medicines | Fondateur | - |
Anciens postes connus de John Mendlein
| Sociétés | Poste | Fin |
|---|---|---|
| FATE THERAPEUTICS, INC. | Fondateur | 13/10/2025 |
| OMEA THER | Directeur/Membre du Conseil | 03/12/2024 |
| ATYR PHARMA, INC. | Directeur Général | 01/11/2017 |
| ░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░ ░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | ░░░░░░░░░░ |
Formation de John Mendlein
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
66
Relations au 1er degré
29
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 29 |
|---|---|
Aurora Biosciences Corp.
 Aurora Biosciences Corp. BiotechnologyHealth Technology Designs and develops proprietary drug discovery systems, services and technologies | Health Technology |
ACLARA Biosciences, Inc.
 ACLARA Biosciences, Inc. Medical SpecialtiesHealth Technology Discovers, develops and markets innovative products to guide and improve treatment of serious viral, immunologic and oncologic diseases | Health Technology |
Monogram Biosciences, Inc.
 Monogram Biosciences, Inc. Miscellaneous Commercial ServicesCommercial Services Provides research and development services for HIV treatment | Commercial Services |
aTyr Pharma, Inc.
 aTyr Pharma, Inc. Pharmaceuticals: MajorHealth Technology Operates as a bio therapeutics company that discovers and develops medicines based on novel biological pathways | Health Technology |
Chimeros, Inc.
 Chimeros, Inc. Pharmaceuticals: MajorHealth Technology Develops novel therapies for cancer treatment | Health Technology |
Biotechnology Innovation Organization
 Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology advocacy organization representing biotech companies, industry leaders and state biotech associations | Commercial Services |
Flagship Pioneering, Inc.
Flagship Pioneering, Inc. Investment ManagersFinance Flagship Pioneering invests in companies located across the globe. The firm targets companies operating in the fields of therapeutics, life science tools & diagnostics, bioenergy, and cleantech sectors. It provides financing for seed, early and later-stage capital requirements. The firm makes co-investments and also acts as a lead investor. | Finance |
University of California, Los Angeles
 University of California, Los Angeles Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Adnexus
 Adnexus Pharmaceuticals: MajorHealth Technology Develops medicines which includes protein antagonists | Health Technology |
University of Miami
 University of Miami Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Affinium Pharmaceuticals Ltd.
 Affinium Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Provides clinical development of antibacterial | Health Technology |
Cooley LLP
 Cooley LLP Miscellaneous Commercial ServicesCommercial Services Provides legal services | Commercial Services |
Fate Therapeutics, Inc.
 Fate Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical stage biopharmaceutical company | Health Technology |
University of California, Hastings
 University of California, Hastings Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Chimeros Therapeutics
Chimeros Therapeutics Medical SpecialtiesHealth Technology Develops cancer therapeutic treatment services | Health Technology |
GlaxoSmithKline Pharmaceuticals SA (Belgium)
 GlaxoSmithKline Pharmaceuticals SA (Belgium) Pharmaceuticals: MajorHealth Technology Develops and manufactures pharmaceuticals and vaccines | Health Technology |
Axcella Health, Inc.
 Axcella Health, Inc. BiotechnologyHealth Technology Provides first-in-class precision therapeutic solutions to diseases with a focus on restoring amino acid biology | Health Technology |
Homes for Sudan | |
Editas Medicine, Inc.
 Editas Medicine, Inc. BiotechnologyHealth Technology Manufactures gene editing medicines | Health Technology |
Ohana Biosciences, Inc.
 Ohana Biosciences, Inc. Miscellaneous Commercial ServicesCommercial Services Operates early stage biotechnology company | Commercial Services |
Omega Therapeutics, Inc.
 Omega Therapeutics, Inc. BiotechnologyHealth Technology Develops therapeutics for general and rare genetic diseases, immunology, inflammation, oncology and metabolic diseases | Health Technology |
Moderna, Inc.
 Moderna, Inc. BiotechnologyHealth Technology Researches, develops, manufactures and commercializes mRNA-based respiratory & other virus vaccines, oncology and rare disease therapeutics | Health Technology |
Repertoire Immune Medicines, Inc.
 Repertoire Immune Medicines, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biotechnology company that engages in immune medicines to prevent, treat and cure cancer | Health Technology |
Senda Biosciences, Inc.
 Senda Biosciences, Inc. BiotechnologyHealth Technology Develops therapeutics to treat diseases | Health Technology |
Tessera Therapeutics, Inc.
Tessera Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that writes therapeutic messages into the genome to treat diseases | Health Technology |
Empress Therapeutics, Inc.
 Empress Therapeutics, Inc. BiotechnologyHealth Technology Provides drug discovery and development services | Health Technology |
Laronde Inc.
 Laronde Inc. Miscellaneous Commercial ServicesCommercial Services Develops an eRNA therapeutic platform that capable diverse proteins inside body | Commercial Services |
Vesalius Therapeutics
Vesalius Therapeutics BiotechnologyHealth Technology Operates as a biotechnology company that develops medicines for common human diseases | Health Technology |
Sail Biomedicines
Sail Biomedicines Pharmaceuticals: MajorHealth Technology Engages in design and deployment of programmable medicines | Health Technology |
